An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems

Indian Journal of Experimental Biology

Volumn 35, Issue 10, 1997, Pages 1025-1031

  Sharma, Sangeeta ^a   Sharma, S C ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL; CLINICAL TRIAL; DRUG SCREENING; GUINEA PIG; HUMAN; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; CYCLOOXYGENASE INHIBITORS; DRUG EVALUATION, PRECLINICAL; EICOSANOIDS; GUINEA PIGS; HUMANS;

EID: 0031241723     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Ouderaa F J Van der, Buytenhek M, Nugteren D H & Van Drop D A, Biochem Biophys Acta, 487 (1977) 315.
2. Rollins T E & Smith W L, J Biol Chem, 255 (1980) 4872.
3. Regier H K, Dewitt D L, Schindler M S & Smith W L, Arch Biochem Biophys, 301 (1993) 439.
4. Hoff T, Dewitt D L, Kaever V, Resch K & Goppelt-Strube M, FEBS Lett, 320 (1993) 38.
5. Smith C J, Morrow J D, Roberts L J & Marnett L J, Biochem Biophys Res Commun ,192 (1993) 787.
6. Brannon T S, North A J, Wells L B & Shaul P W, J Clin Invest, 93 (1994) 2230.
7. DeWitt D L, Biochim Biophys Acta, 1083 (1991) 121.
8. Wu K K, Sanduja R, Tsi A L, Ferhanoglu B & Loose-Mitchell D S, Proc Natl Acad Sci (USA), 88 (1991) 2384.
9. Sylvia W J, Brockman J A, Kaminski M A, DeWitt D L & Smith W L, Mol Androl, 6 (1994) 197.
10. Feng L, Sun W, Xia Y, Tang W W, Chanmugam P, Soyoola E, Wilson C B & Hwang D, Arch Biochem Biophys, 307 (1993) 361.
11. Kargman S, Chan S, Evan J, Vickers P & O'Neill G, J Cell Biochem, 319 (1994) Suppl.18B (Abstr. O:109).
12. Sano H, Hla T, Maier J A M, Crofford L J, Case J P, Maciag T & Wilder R L, J Clin Invest, 89 (1992) 97.
13. Sirois J and Richards J S, J Biol Chem, 268 (1992) 21931.
14. Crofford L J, Wilder R L, Ristimaki A P, Sano H, Remmers E F, Epps H R & Hla T J, Clin Invest, 93 (1994) 1095.
15. Smith W L & Laneuville O, in Eiocosanoids and their inhibitors in tumor immunology and immunotherapy, edited by J E Harris, D P Braun and K M Anderson (CRC Press, Boca Raton, London) 1994, 1.
16. DeWitt D L & Meade E A, Arch Biochem Biophys, 306 (1993) 94.
17. Yamagata K, Anderson K I, Kaufmann W E, Barnes C A & Worley P F Neuron, 11 (1993) 371.
18. Pace-Asciak CR & Astora S, Biol Med, 7 (1989) 409.
19. Yamamoto S, Free Radical Biol Med, 10 (1991) 149.
20. Spector A A, Gordon G A & Moore S A, Prog Lipid Res, 27 (1988) 271.
21. Yoshimoto T, Yamamoto Y, Arakawa T, Suzuki H, Yamamoto S, Yokoyama C, Tanabe T & Toh H, Biochem Biophys Res Commun, 172 (1990) 1230.
22. Funk C D, Funk L B, Fitzgerald G A & Samuelsson B, Proc Natl Acad Sci (USA), 89 (1990) 3962.
23. Rouzer C A, Matsumoto T & Samuelsson B, Proc Natl Acad Sci (USA), 83 (1986) 857.
24. Ueda N, Kaneko S, Yoshimoto T & Yamamoto S, J Biol Chem, 261 (1986) 7982.
25. Fitzpatrick F A & Murphy R C, Pharmacol Rev, 40 (1989) 229.
26. McGiff J C, Ann Rev Pharmacol Toxicol, 31 (1991) 339.
27. Capdevila J H, Kim Y R, Martin-Wixtrom C, Falck J R, Manna S & Westbrook R W, Arch Biochem Biophys, 243 (1991) 8.
28. Hayakawa M, Sugiyama S, Takamura T, Yokoo K, Iwata M, Suzuki K, Taki F, Takahashi S & Ozawa T, Biochem Biophys Res Commun, 137 (1986) 424.
29. Morrow J D, Hill K E, Burk R F, Nammour T M, Badr K & Roberts L J, Proc Natl Acad Sci (USA), 87 (1990) 9383.
30. Devane W A, Hanus L, Breuer A, Pertwee R G, Stevenson L A, Griffin G, Gibson D, Mandelbaum A, Etinger A & Mechoulam R, Science, 258 (1992) 1946.
31. Smith W L, Biochem J, 259 (1989) 315.
32. Needleman P, Turk J, Jakschik B A, Morrison A R & Lefkowith J B, Ann Rev Biochem, 55 (1986) 69.
33. Piper P J & Samhoun M N, Br Med Bull, 43 (1987) 297.
34. William T J & Peck M J, Nature, 270 (1977) 530.
35. Dusting G P, Moncada S & Vane J R, Eur J Pharmacol, 49 (1978) 65.
36. Higgs G A, Moncada S & Vane J R, Prostaglandins, 16 (1978) 153.
37. Moncada S & Vane J R, Pharmacol Rev, 30 (1979) 293.
38. Lewis G P, Westwick J & Williams T J, Brit J Pharmacol, 59 (1977) 442.
39. Humes J L Bonney R J, Pelus L, Dahlgren, M E, Sadowski S J & Davies P, Nature, 269 (1977) 149.
40. Bonney R J, Naruns P P, Davies P & Humes J L, Prostaglandins, 18 (1979) 605.
41. Feuerstein G, Prostaglandins, 27 (1984) 781.
42. Piper P J, Physiol Rev, 64 (1984) 744.
43. Sharma S C & Gulati O P, in Recent Advances in Microcirculatory Research no. 20, edited by P G Köln (S. Karger, Basel) 1981, 467.
44. Gulati O P, Sharma S C & Hammersen F, Archs Int Pharmacodyn Ther, 263 (1983) 272.
45. Harada Y, Hatanaka Ko, Kawamura M, Saito M, Ogino M, Majima M, Ohno T, Ogino K, Yamàmoto K, Taketani Y, Yamamoto S & Katori M, Prostaglandins, 51 (1996) 19.
46. Moncada S, Ferrieira S H & Vane J R, in Inflammation handbook of expeimental pharmacology, vol. 50, edited by S H Ferrieira and J R Vane (Springer-Verlag, Berlin) 1978, 588.
47. Samuelsson B, Science, 220 (1983) 568.
48. Davies P, Bailey P J & Goldenberg M M, Ann Rev Immunol, 2 (1984) 335.
49. Beodi M J Hensby C N, Park A & Gordon D, Life Sci , 27 (1980) 603.
50. Flower R J, Phamacol Rev, 26 (1974) 33.
51. Vane J R, Nature (London), 231 (1971) 232.
52. Smith J B & Willis A L, Nature (London), 231 (1971) 235.
53. Roth G J, Stanford N & Majerus P W, Proc Natl Acad Sci (USA), 72 (1975) 3073.
54. Lands W E M & Hansel A M, in Prostaglandins and related substances, edited by C Pace-Asciak and K Granstrom (Elsevier, Amsterdam) 1983, 203.
55. Williams C S and Du Bois N, Am J Physiol, 270 (1996) (3 pt 1) G393.
56. Insel P A, in The pharmacological basis of therapeutics edited by J.G.Hardman, L E Limbird, P.B. Molinoff, R.W. Ruddon and G Gilman (McGraw-Hill Publ. New York) 1996, 617.
57. Mizuno K, Yamamoto S & Lands A M, Prostaglandins , 23 (1983) 743.
58. Ouderaa van der F J, Buytenhek M, Nugteren D H & van Drop D A, Eur J Biochem, 109 (1980) 1.
59. Lecomte M, Laneuville O, Ji C, DeWitt D L and Smith W L, J Biol Chem, 269 (1994) 13207.
60. O'Neill G P, Mancini J A, Kargman S, Yergey J, Kwan M Y, Falgueyret J -P, Abramovitz M, Kennedy B P, Quellet M, Cromlishm W, Culp S, Evans J F, Ford-Hunchinson A W & Wickers P J, Mol Pharmacol, 45 (1994) 245.
61. Moncada S, Gryglewski R L, Bunting B and Vane J R, Prostaglandins, 12 (1976) 715.
62. Ham E A, Egan R W Soderman D D, Gale P H and Kuehl F A, J Biol Chem, 254 (1979) 2191.
63. Adcock J J, Garland L G, Moncada S. and Salmon J J, Prostaglandins, 16 (1978) 163.
64. Lanevulle O, Breuer D K, Dewitt D L, Hla T, Colin D, Funk D and Smith W L, J Pharmacol Exptl Ther, 271 (1994) 927.
65. Mitchell J A, Akarasereenont C, Flower R J & Vane J R, Proc Natl Acad Sci (USA), 90 (1993)11697.
66. Vane J R & Bonting R M, Scand J Rheumatol, 25 (1996) Suppl.102) 9.
67. Engelhardt G, Meloxicam: A potent inhibitor of COX-2, Nineth International Conference on Prostaglandins and Related Compounds, held at Florence (Italy) (1994) p 82.
68. Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B, Tsing S, Bach C, Freire J, Hardy C, Elliott S & Ramesha C, Biochim Biophys Acta, 1209 (1994) 130.
69. Patrignani P, Panara M R, Greco A, Fusco O, Natoli C, Iacobelli S, Cipollone F, Ganci A, Creminon C, Maclouf J & Patrono, C, J Pharmacol Exp Ther, 271 (1994) 1705.
70. Vane, J.R, Lancet, 346 (1995) 1105.
71. Bennett A and Tavares I A, Lancet, 346 (1995) 1105.
72. Huskisson E C, Ghozlan R, Kurthen R, Degner F L & Bluhmki E, Br J Rheumatol, 35 (1996) 29.